Related Experiment Video

Updated: Aug 15, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

The polyphenols quercetin and catechin synergize in inhibiting platelet CD40L expression

Pasquale Pignatelli, Serena Di Santo, Roberto Carnevale

    Thrombosis and Haemostasis
    |November 8, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Microfluidics in Assessing Platelet Function
    06:47

    Microfluidics in Assessing Platelet Function

    Published on: November 8, 2024

    Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
    09:13

    Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

    Published on: April 6, 2017

    Related Experiment Videos

    Last Updated: Aug 15, 2026

    Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
    08:04

    Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

    Published on: June 10, 2025

    Microfluidics in Assessing Platelet Function
    06:47

    Microfluidics in Assessing Platelet Function

    Published on: November 8, 2024

    Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
    09:13

    Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

    Published on: April 6, 2017

    Related Concept Videos

    Inhibition of CDK Activity02:34

    Inhibition of CDK Activity

    The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
    Inhibition of Cdk Activity02:34

    Inhibition of Cdk Activity

    The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

    Articles linked to this work by shared authors, journal, and citation graph.

    Peripheral Artery Disease and Atrial Fibrillation: A Systematic Review and Meta-analysis on 763,919 Patients.

    JACC. Advances·2026

    Effects of direct oral anticoagulants on cardiac outcomes in atrial fibrillation: a systematic review and network meta-analysis.

    Internal and emergency medicine·2026

    Rationale and design of the RISE-HF trial: sucrosomial iron in heart failure.

    International journal of cardiology. Heart & vasculature·2026

    Prognostic Role of Serum Albumin Levels in Elderly Patients With Non-Valvular Atrial Fibrillation.

    European journal of clinical investigation·2026

    Age-Related Platelet Cox-1 Upregulation in Atrial Fibrillation.

    International journal of molecular sciences·2026

    Pharmacological rhythm control strategy and outcomes in the oldest atrial fibrillation patients: an analysis of the nationwide Italian START registry.

    Age and ageing·2026

    Clinical Characteristics and Early Outcomes of Acute Pulmonary Embolism Presenting with Syncope.

    Thrombosis and haemostasis·2026

    Association of Admission Immature Platelet Fraction with Long-Term Mortality Following Primary Percutaneous Coronary Intervention for STEMI.

    Thrombosis and haemostasis·2026

    Recent Trials of Left Atrial Appendage Closure versus Oral Anticoagulants: An Optimistic View.

    Thrombosis and haemostasis·2026

    Divergent Effects of Estradiol Regimens on Protein S and Global Coagulation in Transgender Women.

    Thrombosis and haemostasis·2026

    Ambient Particulate Matter Exposure and Risk of Venous Thromboembolism: An Updated Systematic Review and Meta-Analysis.

    Thrombosis and haemostasis·2026

    Mouse Models to Study Von Willebrand Factor in Hemostasis: A Scoping Review.

    Thrombosis and haemostasis·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us